Abstract

Disorders of Sex Development (DSD) are anomalies occurring in the process of fetal sexual differentiation that result in a discordance between the chromosomal sex and the sex of the gonads and/or the internal and/or external genitalia. Congenital disorders affecting adrenal function may be associated with DSD in both 46,XX and 46,XY individuals, but the pathogenic mechanisms differ. While in 46,XX cases, the adrenal steroidogenic disorder is responsible for the genital anomalies, in 46,XY patients DSD results from the associated testicular dysfunction. Primary adrenal insufficiency, characterized by a reduction in cortisol secretion and overproduction of ACTH, is the rule. In addition, patients may exhibit aldosterone deficiency leading to salt-wasting crises that may be life-threatening. The trophic effect of ACTH provokes congenital adrenal hyperplasia (CAH). Adrenal steroidogenic defects leading to 46,XX DSD are 21-hydroxylase deficiency, by far the most prevalent, and 11β-hydroxylase deficiency. Lipoid Congenital Adrenal Hyperplasia due to StAR defects, and cytochrome P450scc and P450c17 deficiencies cause DSD in 46,XY newborns. Mutations in SF1 may also result in combined adrenal and testicular failure leading to DSD in 46,XY individuals. Finally, impaired activities of 3βHSD2 or POR may lead to DSD in both 46,XX and 46,XY individuals. The pathophysiology, clinical presentation and management of the above-mentioned disorders are critically reviewed, with a special focus on the latest biomarkers and therapeutic development.

Highlights

  • The term Disorders of Sex Development (DSD) refers to a wide range of anomalies occurring in the process of fetal sexual differentiation of the gonads and/or the genitalia, resulting in discordance between the chromosomal sex and the gonads and/or the internal and/or external genitalia.1.1 The Physiology of Fetal Sex DifferentiationThe chromosomal sex is determined at fertilization, depending on whether the spermatozoon carries an X or a Y chromosome

  • In the classic salt wasting form of 21OHD, residual enzymatic activity is less than 1%, with both cortisol and aldosterone deficiencies resulting in life-threatening adrenal crises in the first 2 weeks of life, which can be anticipated if neonatal screening for congenital adrenal hyperplasia (CAH) is performed

  • If liquid chromatography–tandem mass spectrometry is not available, occasionally an ACTH stimulation test is recommended to distinguish 21OHD from other adrenal steroidogenic defects, especially in individuals with borderline 17-hydroxyprogesterone [26]

Read more

Summary

INTRODUCTION

The term Disorders of Sex Development (DSD) refers to a wide range of anomalies occurring in the process of fetal sexual differentiation of the gonads and/or the genitalia, resulting in discordance between the chromosomal sex and the gonads and/or the internal and/or external genitalia

The Physiology of Fetal Sex Differentiation
Pathogenesis of DSD
DSD ASSOCIATED WITH ADRENAL DISORDERS
The Role of 11-Oxygenated Androgens in Hyperandrogenic Adrenal Disorders
MANAGEMENT OF PATIENTS WITH DSD ASSOCIATED TO ADRENAL DYSFUNCTION
Management of Genital and Reproductive Issues
Management of Adrenal Steroidogenic Dysfunction
Findings
CONCLUDING REMARKS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.